Jump to content

Critical Reviews in Toxicology: Difference between revisions

From IdeaWazaWiki
wikademia>James w Davis
No edit summary
wikademia>Neurolysis
Line 1: Line 1:
{{Infobox Journal
{{Infobox Journal
| title        = Critical Reviews in Toxicology
| title        = Critical Reviews in Toxicology
| cover = [[Image: Critical Reviews in Toxicology.jpg|150px]]
| cover = [[Image: Critical Reviews in Toxicology.jpg|150px|{{puic|1=Critical Reviews in Toxicology.jpg|log=2009 March 12}}]]
| editor      = Dr Roger O. McClellan, PhD
| editor      = Dr Roger O. McClellan, PhD
| discipline  = Toxicology, public health
| discipline  = Toxicology, public health

Revision as of 19:37, 12 March 2009

Critical Reviews in Toxicology  
This content has an uncertain copyright status and is pending deletion. You can comment on its removal.
Abbreviated title Crit Rev Toxicol
Discipline Toxicology, public health
Language English
Edited by Dr Roger O. McClellan, PhD
Publication details
Publisher Informa Pharmaceutical Science ({{{country}}})
Open access no
Impact factor 5.145 (2007)
Indexing
ISSN 1040-8444 (print)
15476898 (web)
Links

Critical Reviews in Toxicology is an academic journal that publishes review articles on the mechanisms, responses and assessments of toxins and toxicants.

Core Therapeutic Areas

  • toxicology of commodity and specialty chemicals; pharmaceutical agents, consumer products such as macronutrients and food additives, and environmental agents such as ozone and dioxin
  • toxicological effects from subtle physiological alterations to overt toxicity manifested in major systems, such as respiratory, gastrointestinal, endocrine, urogenital, musculoskeletal, nervous and immunological systems
  • mechanisms of action at all levels of biological organisation, from macromolecules and cells to integrated organisms and populations of laboratory animals and people

Critical Reviews in Toxicology is owned by Informa plc (LSE: INF) which is a United Kingdom-based publisher and conference company, with offices in more than 40 countries and more than 10,000 employees.[1] The Company is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index.[2]

Editor-in-Chief

Roger O. McClellan, Ph.D, is the Editor-in-Chief of Critical Reviews in Toxicology[3]. Dr. McClellan currently works as an Advisor in Inhalation Toxicology and Human Health Risk Analysis from his home office in Albuquerque, NM.[4]. He is the author of more than 350 papers and edited 10 books in these fields including the 2 leading texts on inhalation toxicology/respiratory toxicology.

Publication Format

Critical Reviews in Toxicology publishes 10 issues per year in simultaneous print and online editions and is available on a subscription basis. Individual articles can be purchased on a pay-per-view basis. The full text of all articles is offered in PDF and PDF Plus formats. All back-issues of the journal are available online and are hosted on the publisher's website.

Subscribers to the electronic edition of Critical Reviews in Toxicology receive access to the online archive, which dates back to 1971, as part of their subscription[5].

References

  • Critical Reviews in Toxicology homepage of Critical Reviews in Toxicology
  • informapharmascience.com homepage of Informa Pharmaceutical Science, the division of Informa that publishes Critical Reviews in Toxicology
  • Informa UK Ltd Informa plc is the leading international provider of specialist information and services for the academic and scientific, professional and commercial business communities.